论文部分内容阅读
目的研究采用阿托伐他汀钙治疗慢性充血性心力衰竭的临床效果。方法 100例慢性充血性心力衰竭患者,随机分为观察组与对照组,各50例,对照组采取充血性心力衰竭常规治疗,观察组在此基础上增加阿托伐他汀钙治疗,对比两组患者治疗后心功能指标变化情况。结果治疗后观察组左室舒张末内径(LVDD)为(45.16±7.10)mm,显著低于对照组的(58.64±7.94)mm;观察组左室射血分数(LVEF)为(48.60±13.06)%、每分钟搏量(SV)为(80.31±13.48)ml、每分钟心排血量(CO)为(5.36±1.49)L/min,显著高于对照组的(40.34±12.41)%、(70.81±10.64)ml、(5.01±1.27)L/min,差异均有统计学意义(P<0.05)。结论阿托伐他汀钙联合常规治疗措施可显著改善慢性充血性心力衰竭患者心功能,具有较高的临床应用价值。
Objective To study the clinical effects of atorvastatin calcium in the treatment of chronic congestive heart failure. Methods 100 cases of chronic congestive heart failure patients were randomly divided into observation group and control group, 50 cases in each group. The control group was given conventional treatment of congestive heart failure. On the basis of the above, the observation group received atorvastatin calcium treatment. Changes in cardiac function after treatment. Results After treatment, the left ventricular end-diastolic diameter (LVDD) in the observation group was (45.16 ± 7.10) mm, which was significantly lower than that in the control group (58.64 ± 7.94) mm. The LVEF in the observation group was (48.60 ± 13.06) %, And the volume of cardiac output per minute was (80.31 ± 13.48) ml and (5.36 ± 1.49) L / min, which was significantly higher than that of the control group (40.34 ± 12.41)% and 70.81 ± 10.64) ml and (5.01 ± 1.27) L / min, respectively, with statistical significance (P <0.05). Conclusions Atorvastatin combined with conventional treatment can significantly improve the cardiac function in patients with chronic congestive heart failure and has high clinical value.